FGF2/FGFR1 induces resistance to radiotherapy in GBM, and inhibition of FGFR1 reduces radioresistance in GBM mouse xenografts, although tumor growth is not reduced by FGFR1 silencing alone without irradiation [8,9,10]. The gene discussed is FGF2; the disease is neoplasm.